We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Predictors of changes in hemoglobin levels in patients with chronic hepatitis C treated with ribavirin plus pegylated interferon-α.
- Authors
Hu, Ching-Chih; Weng, Cheng-Hao; Lin, Chih-Lang; Tien, Hui-Ching; Kuo, Yen-Lin; Chien, Cheng-Hung; Yen, Cho-Li; Lin, Chun-Yen; Chien, Rong-Nan
- Abstract
Combination therapy with pegylated interferon (pegIFN)-α and ribavirin (RBV) for chronic hepatitis C virus (HCV) infection is associated with reduction in hemoglobin (Hb) concentrations and anemia. The aim of this study was to evaluate the magnitude and frequency of change in Hb and determine the predictive risk factors for Hb decrease during this therapy.
- Publication
Renal failure, 2012, Vol 34, Issue 4, p429
- ISSN
1525-6049
- Publication type
Journal Article
- DOI
10.3109/0886022X.2011.650562